ANIX ANIX
Company Profile ↓Company Overview
ANIX (ANIX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue +0.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -9.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -9.87% |
| 1 Year: | 0.00% |
Stock Price Performance
| 1 Year: | +4.60% |
| 6 Months: | +12.17% |
| 3 Months: | +13.67% |
| 1 Month: | +15.20% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)54.30 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -9.9% CAGR over 5 years.
- Trading 34.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Apr 2013 | Jul 2013 | Jan 2014 | Apr 2014 | Jul 2014 | Jan 2015 | Apr 2015 | Jul 2015 | Jan 2016 | Apr 2016 | Jul 2016 | Jan 2017 | Apr 2017 | Jul 2017 | Jan 2018 | Apr 2018 | Jul 2018 | Jan 2019 | Apr 2019 | Jul 2019 | Jan 2020 | Apr 2020 | Jul 2020 | Jan 2021 | Apr 2021 | Jul 2021 | Jan 2022 | Apr 2022 | Jul 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 513.00K | - | - | - | - | - | - | 210.00K | - | - | - | - | - | - | - | - | - |
| Operating Income | -1.85M | -2.22M | -1.96M | -1.36M | -159.58K | 3.86M | -2.13M | -1.49M | -1.47M | -1.15M | -974.88K | -1.39M | -1.21M | -1.73M | -1.87M | -1.40M | -5.61M | -4.98M | -2.59M | -2.18M | -2.63M | -2.67M | -2.44M | -2.23M | -2.44M | -4.39M | -3.88M | -3.59M | -2.80M | -2.56M | -2.56M | -2.84M | -3.61M | -3.47M | -3.59M | -3.39M | -3.00M | -2.44M | -2.72M | -2.65M |
| Net Income | -2.48M | -2.58M | -3.61M | -3.25M | 411.00K | 3.75M | -2.24M | -1.60M | -1.59M | -1.27M | -1.10M | -3.60M | 160.49K | -1.79M | -1.84M | -1.38M | -5.48M | - | - | -2.14M | -2.59M | -2.64M | -2.56M | -2.21M | -2.40M | -4.33M | -3.83M | -3.54M | -2.75M | -2.32M | -2.29M | -2.51M | -3.25M | -3.14M | -3.28M | -3.18M | -2.79M | -2.26M | -2.56M | -2.52M |
| Diluted EPS | - | - | -0.02 | - | 0.04 | 0.41 | - | -0.18 | -0.18 | -0.15 | - | - | 0.02 | - | - | -0.08 | - | - | - | - | - | - | - | - | - | - | - | - | -0.09 | 0.08 | -0.07 | -0.08 | -0.10 | -0.10 | -0.10 | -0.10 | -0.09 | -0.07 | -0.08 | -0.07 |
| R&D Expense | - | - | - | - | - | - | - | - | 458.05K | 392.59K | 292.06K | 451.63K | 431.12K | 362.97K | 777.87K | 660.19K | 2.94M | 2.25M | 1.27M | 1.09M | 1.49M | 1.23M | 1.25M | 828.00K | 1.02M | 2.17M | 1.84M | 1.74M | 1.45M | 1.07M | 998.00K | 1.09M | 1.35M | 1.65M | 1.93M | 1.55M | 1.32M | 1.05M | 1.10M | 1.26M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Oct 2010 | Oct 2011 | Oct 2012 | Oct 2013 | Oct 2014 | Oct 2015 | Oct 2016 | Oct 2017 | Oct 2018 | Oct 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 730.67K | 1.00M | 947.09K | 388.85K | 3.67M | 9.26M | 300.00K | 362.50K | 1.11M | 250.00K | - | 512.00K | - | 210.00K | 210.00K | - |
| Operating Income | -5.25M | -5.03M | -4.13M | -7.92M | -5.04M | -944.76K | -4.51M | -6.08M | -14.29M | -11.89M | -9.98M | -13.14M | -13.88M | -11.01M | -13.83M | -11.70M |
| Net Income | -5.18M | -7.38M | -4.25M | -10.08M | -9.61M | -1.38M | -5.02M | -5.01M | -14.00M | -11.65M | -10.02M | -12.95M | -13.60M | -9.81M | -12.55M | -10.93M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | 0.45 | -0.32 | -0.39 | -0.34 |
| R&D Expense | 3.01M | 3.12M | 2.21M | - | - | 711.39K | 1.56M | 1.60M | 6.81M | 5.47M | 4.38M | 6.19M | 6.70M | 4.77M | 6.40M | 5.07M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Oct 2009 | Oct 2010 | Oct 2011 | Oct 2012 | Oct 2013 | Oct 2014 | Oct 2015 | Dec 2015 | Oct 2016 | Oct 2017 | Oct 2018 | Oct 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 10.05M | 8.65M | 5.66M | 5.44M | 9.06M | 9.34M | - | 5.63M | 8.81M | 6.45M | 6.29M | 9.45M | 36.26M | 30.41M | 25.52M | 21.59M | 16.08M |
| Total Equity | 4.45M | 4.60M | 1.06M | -1.19M | -3.32M | 4.01M | 5.05M | - | 987.48K | 7.92M | 5.43M | 5.24M | 8.76M | 35.44M | 29.05M | 24.34M | 20.00M | 15.16M |
| Cash & Equivalents | 1.45M | 1.09M | 774.04K | 339.69K | 898.17K | 3.36M | 4.37M | - | 2.49M | 3.34M | 3.06M | 3.49M | 6.42M | 29.13M | 12.36M | 915.00K | 1.27M | 1.24M |
| Long Term Debt | - | - | - | - | - | - | 370.18K | 370.18K | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | 8.76M | 5.05M | 4.28M | - | 4.64M | 889.49K | - | - | 1.19M | 1.49M | 2.21M | 2.15M | 2.70M | 2.13M |
| Current Liabilities | - | 450.12K | 2.11M | 1.82M | 3.21M | 1.81M | 593.78K | - | 468.76K | 889.49K | 1.27M | 1.48M | 1.19M | 1.27M | 2.04M | 2.03M | 2.50M | 1.97M |
Cash Flows (Annual)
Figures in USD.
| Metric | Oct 2010 | Oct 2011 | Oct 2012 | Oct 2013 | Oct 2014 | Oct 2015 | Oct 2016 | Oct 2017 | Oct 2018 | Oct 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.41M | -716.00K | -3.14M | -3.19M | -2.38M | 1.36M | -3.38M | -3.80M | -4.27M | -4.74M | -6.18M | - | -6.49M | -6.21M | -7.33M | -7.17M |
| Investing Cash Flow | 799.69K | -2.14M | 1.75M | 499.32K | -2.51M | 45.22K | 1.50M | -2.74M | 1.46M | -525.46K | -305.79K | - | -10.73M | -5.60M | 4.28M | 4.87M |
| Financing Cash Flow | 1.25M | 2.53M | 958.45K | 3.25M | 7.35M | -400.62K | -2.68K | 7.38M | 2.53M | 5.70M | 9.41M | - | 452.00K | 366.00K | 3.42M | 2.28M |
| Capital Expenditure | -2.07K | -9.03K | -1.60K | - | -6.68K | -54.78K | -146.52K | -30.19K | -38.40K | -175.46K | -15.79K | - | - | - | - | - |
| Free Cash Flow | -2.41M | -725.03K | -3.14M | - | -2.39M | 1.31M | -3.53M | -3.83M | -4.31M | -4.92M | -6.19M | - | -6.49M | -6.21M | -7.33M | -7.17M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | -16.77M | -11.45M | 356.00K | -27.00K |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.00K | - |
Ratios (Annual)
Figures in %.
| Metric | Oct 2010 | Oct 2011 | Oct 2012 | Oct 2013 | Oct 2014 | Oct 2015 | Oct 2016 | Oct 2017 | Oct 2018 | Oct 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | -718.3% | -501.2% | -436.6% | -2,036.2% | -137.5% | -10.2% | -1,503.0% | -1,676.0% | -1,284.4% | -4,756.0% | - | -2,565.6% | - | -5,243.3% | -6,586.2% | - |
| Net Margin % | -708.3% | -735.5% | -449.0% | -2,592.3% | -261.9% | -14.9% | -1,672.1% | -1,381.8% | -1,258.1% | -4,658.8% | - | -2,530.1% | - | -4,671.9% | -5,978.1% | - |
| ROE % | -112.6% | -697.3% | 356.2% | 303.6% | -239.6% | -27.3% | -508.0% | -63.2% | -257.5% | -222.5% | -114.3% | -36.6% | -46.8% | -40.3% | -62.8% | -72.1% |
| ROCE % | -54.7% | -76.9% | -107.7% | -355.4% | -69.6% | -10.8% | -87.4% | -76.7% | -275.7% | -247.1% | -120.7% | -37.5% | -48.9% | -46.9% | -72.4% | -82.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ANIX
Anixa Biosciences (ANIX) CEO purchases 5,000 company shares - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPZ09aWVFnQ2ZKbHJLSWc2U1NWeTZTbnM3cXF4T0plQ29fVDFsd2NOY0JucHNPUzMzVUF2ZHhYZWEyNk9GaUFWT3BxelpmVmYwQ0dEd2sxR1NPQ0lWcDdfSGhPdHYtcmg4YU8zekNOcXlVOVZha05SVnMwWkRYRFFkelZjWWl2SVk5YjNxaz…
Here's Why You Should Add ANIX Stock to Your Portfolio Now - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOY2NiOVM1VDRmTlYyS0ptcTRncnRpQnFOZjAzTThiMk1Yd2NoelI4b2RRUGR3eldUQ01PZkZRYXNiZWUxQzhkaGRnWkJ6cmRqX1YwOUJlcEgwZldUMjV2c004LVBWNnd3VzZWLVg5RHo2OXk2YU5aN0ZhRXFNVGF6bTFVd2VRdjRyLTA4NU…
$ANIX stock is down 10% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPbUlPclNuNjhPWExsbVFFSUVUQTg5NWZjclJ3SUpSZlJOR2o2REhWSl9hOGgyWDlGTHZGRFRKRi05eVV3a3hrelR2M1lsVzQ0NDVPTnpTUXY0T2JuSExwLTl2dEhBS3RCODdTR1VOSXEwN0RpdDZXYmkyOUFWWjZ6SjRXZ3lVb2JyVlJJMV…
ANIX Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBjQnRaS09wdEhIU1ZNUnFtTDZtdFR5bVdPR1ZYU2xJVFhoNjZ1OUhjNEhpTk5fb1pqWDAyWjJSbGNXQUlEUk9PTDNROGNVRXVTUGhhdjFxUERaWmNHd3JDSzc1Qk44S3pMYndPRVF0RzFBUVVyaHFxQjlB?oc=5" target="_blank">ANI…
Anixa Biosciences (ANIX) CEO Amit Kumar Buys 5,000 Shares, Insider Ownership Climbs to 657,000 Shares - GuruFocus
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPMTQzQkpWaHR5SzY5dmVBTUl5Rlh4aE9LXzJlRlhtVVIyMl9MaDhxVDkzYkZ4X0hYSUxZUF9qeGE2MWRzQnlTVkRKeGRKR2FoVTFuM0RkOFNUSGhMbHphQjM1OFJ0SGJGeHk3THFxM19wdjctdi0yRXhlaGxraHdXU2NSYV9lX3JZUGRlTW…
Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance UK
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQSF8zckk1akotaGw5Rmd2Z1N1MTlzaEViX0VoYXdKNkcxZ3ZkSXozQ3BqSENib0xkOTRwUnRvbm5PWWR4bUJwX0ZSX3VRc2FXb3hfaHBpUHZiSm83d3hOdmFjQVdTMzM0NlY5Ulk3YUZuR1FLUkIydkRhQkhKYnRXc280dXRhMVdJai1Sek…
ANIX — Frequently Asked Questions
What is the current share price of ANIX?
As of 2026-08-05 17:25 PDT, ANIX trades at $3.41 on NASDAQ/NYSE. Its 52-week range is $2.35 to $5.22.
What is the P/E ratio of ANIX?
ANIX trades at a trailing price-to-earnings (P/E) ratio of -10.03.
What is the return on equity (ROE) of ANIX?
ANIX has a return on equity (ROE) of -72.07%. Its return on capital employed (ROCE) is -82.91%.
Is ANIX a good stock to buy?
This page provides a data-driven analysis of ANIX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.